Moleac will be attending the 19ᵗʰ World Congress of Neurosurgery (WFNS) in Dubai from December 1–5, 2025.

We are proud to share that our colleague Xin Yan Lim, Head of Pharma Partnerships at Moleac, was recently invited as a speaker at the Bpifrance seminar in Singapore, dedicated to “The Role of Research and Industry in Shaping the Future of Health.”

We are pleased to share highlights from the Neurological Disorders Scientific Summit held in Rome, Italy, from 20 to 23 November 2025.

Alzheimer’s Disease is a complex neurodegenerative disorder affecting millions worldwide.

What causes spasticity after a stroke, and how can it be managed?

Together with our partner EP Plus Group, Moleac was delighted to organise a dinner symposium focused on “Expanding Approaches in Alzheimer’s Disease Management,” held on 15 November in Kuala Lumpur.

Moleac was proud to participate in the 5th African Stroke Organization Conference (ASOC 2025) held in Nairobi, Kenya, from 3–5 November.

We are thrilled to announce our participation at the 19ᵗʰ World Congress of Neurosurgery (WFNS), in Dubai from December 1–5, 2025.

Moleac was honoured to participate in the 2025 International Stroke Conference, held on November 8 in Hanoi, Vietnam, which brought together over 1,200 leading healthcare professionals from Vietnam and around the world..

This past weekend, E*Chi’mes Pharmaceutical Inc., in collaboration with Moleac, organized a symposium on the Advances in Alzheimer’s Disease.

Last weekend in Bangkok, we brought together neurologists and neurosurgeons from across the region to share insights and strengthen collaboration in the management of Traumatic Brain Injury, Intracerebral Haemorrhage, and Spinal Cord Injury.

Since 2022, Moleac proudly supports the Kythe Foundation, a Philippines-based non-profit organisation improving the quality of life for children with cancer and..